Pritesh Morar

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 356 citations

Medicine, Clinical Sciences, Surgery +12

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 179 citations

Medicine, Surgery, Gastroenterology +10

Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease--Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome

Pritesh Morar, J. D. Hodgkinson, S. Thalayasingam et al. · Journal of Crohn s and Colitis · 2015 · 109 citations

Medicine, Perioperative Medicine, Surgery +15

Impact of postoperative non-steroidal anti-inflammatory drugs on adverse events after gastrointestinal surgery

Stephen J. Chapman, James Glasbey, Michael E. Kelly et al. · British journal of surgery · 2014 · 93 citations · Full text

Medicine, Perioperative Medicine, Surgery +15

Defining the optimal design of the inflammatory bowel disease multidisciplinary team: results from a multicentre qualitative expert-based study

Pritesh Morar, Sonal Arora, Ailsa Hart et al. · Frontline Gastroenterology · 2015 · 41 citations · Full text

Nursing, Surgery, Gastroenterology +13